Octagon Capital Advisors LP ARRIVENT BIOPHARMA INC Transaction History

Octagon Capital Advisors LP

  • $307 Million
  • Q3 2025
Number of Shares
1,971,054
Previous 1,946,054 1.28%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
N/A
25,000 Added 1.28%
1,971,054 $0
Q2 2025

Aug 14, 2025
SELL
N/A
-113,333 Reduced 5.5%
1,946,054 $0
Q1 2025

May 16, 2025
BUY
N/A
2,059,387 New
2,059,387 $0
Q4 2024

Feb 14, 2025
BUY
N/A
83,000 Added 4.2%
2,059,387 $0
Q3 2024

Nov 14, 2024
BUY
N/A
173,083 Added 9.6%
1,976,387 $0
Q2 2024

Aug 14, 2024
SELL
N/A
-140,532 Reduced 7.23%
1,803,304 $0
Q1 2024

May 15, 2024
BUY
N/A
1,943,836 New
1,943,836 $0
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email